Page last updated: 2024-11-03

probenecid and Carcinoma, Anaplastic

probenecid has been researched along with Carcinoma, Anaplastic in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research Excerpts

ExcerptRelevanceReference
" There is substantial evidence that N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) is deformylated to 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in the process of FANFT-induced bladder cancer."3.67Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat. ( Cohen, SM; Davis, BB; Spry, LA; Zenser, TV, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spry, LA1
Zenser, TV1
Cohen, SM1
Davis, BB1

Other Studies

1 other study available for probenecid and Carcinoma, Anaplastic

ArticleYear
Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
    The Journal of clinical investigation, 1985, Volume: 76, Issue:3

    Topics: Administration, Oral; Animals; Aspirin; Carcinoma; FANFT; Glomerular Filtration Rate; In Vitro Techn

1985